BOSCO, Raffaella
Distribuzione geografica
Continente | # |
---|---|
NA - Nord America | 206 |
EU - Europa | 19 |
AS - Asia | 10 |
AF - Africa | 3 |
Totale | 238 |
Nazione | # |
---|---|
US - Stati Uniti d'America | 204 |
CN - Cina | 9 |
IT - Italia | 9 |
FR - Francia | 6 |
DE - Germania | 3 |
ZA - Sudafrica | 3 |
CA - Canada | 2 |
GB - Regno Unito | 1 |
IN - India | 1 |
Totale | 238 |
Città | # |
---|---|
Fairfield | 38 |
Ashburn | 21 |
Cambridge | 20 |
Woodbridge | 19 |
Seattle | 16 |
Wilmington | 12 |
Buffalo | 11 |
Santa Cruz | 8 |
Houston | 7 |
Modena | 6 |
Des Moines | 5 |
Ann Arbor | 4 |
Beijing | 4 |
Chicago | 4 |
Clearwater | 3 |
Las Vegas | 3 |
Muizenberg | 3 |
San Diego | 3 |
University Park | 3 |
Wuhan | 3 |
Bangalore | 1 |
Boardman | 1 |
Bremen | 1 |
Cornaredo | 1 |
Council Bluffs | 1 |
Fleming Island | 1 |
Hamilton | 1 |
Liberty Lake | 1 |
Milan | 1 |
Mountain View | 1 |
Phoenix | 1 |
Provo | 1 |
Riva | 1 |
Rome | 1 |
San Francisco | 1 |
Scottsdale | 1 |
Scranton | 1 |
Shanghai | 1 |
Simi Valley | 1 |
Toronto | 1 |
Totale | 213 |
Nome | # |
---|---|
Reversal of the glycolytic phenotype of primary effusion lymphoma cells by combined targeting of cellular metabolism and PI3K/Akt/ mTOR signaling, file e31e124b-0de0-987f-e053-3705fe0a095a | 182 |
Parvoviruses in blood donors and transplant patients, Italy, file e31e124e-1af7-987f-e053-3705fe0a095a | 59 |
Dasatinib Plus Nutlin-3 Shows Synergistic Antileukemic Activity inBoth p53wild-type and p53mutated B Chronic Lymphocytic Leukemias by Inhibitingthe Akt Pathway, file e31e124a-ae19-987f-e053-3705fe0a095a | 3 |
Totale | 244 |
Categoria | # |
---|---|
all - tutte | 1.087 |
article - articoli | 0 |
book - libri | 0 |
conference - conferenze | 0 |
curatela - curatele | 0 |
other - altro | 0 |
patent - brevetti | 0 |
selected - selezionate | 0 |
volume - volumi | 0 |
Totale | 1.087 |
Totale | Lug | Ago | Sett | Ott | Nov | Dic | Gen | Feb | Mar | Apr | Mag | Giu | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2018/2019 | 17 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 7 | 7 |
2019/2020 | 50 | 4 | 3 | 2 | 3 | 2 | 6 | 5 | 6 | 9 | 4 | 3 | 3 |
2020/2021 | 65 | 4 | 6 | 2 | 8 | 2 | 3 | 3 | 3 | 5 | 15 | 13 | 1 |
2021/2022 | 61 | 4 | 9 | 15 | 0 | 5 | 0 | 6 | 1 | 2 | 2 | 14 | 3 |
2022/2023 | 24 | 1 | 0 | 8 | 3 | 1 | 6 | 2 | 0 | 0 | 0 | 3 | 0 |
2023/2024 | 16 | 0 | 1 | 1 | 1 | 1 | 1 | 2 | 4 | 3 | 2 | 0 | 0 |
Totale | 244 |